We crafted a deck as beautiful as the story of this women's healthcare company that was acquired by Organon for $240 million.
Alydia Health’s innovative yet simple device, the Jada® System, is designed to encourage normal contraction of the uterus to stop excessive bleeding after childbirth. We worked with the clinical team at Alydia to help share the results of the the company’s pivotal PEARLE IDE Study, which resulted in 510(k) clearance (marketing authorization) from the FDA.
Alydia was acquired by Organon in 2021 for $240 million.